Columbia Laboratories to Report Third Quarter 2001 Results, Conference Call to be Held.Business Editors/Health & Medical Writers NEW YORK--(BUSINESS WIRE)--Nov. 9, 2001 Columbia Laboratories, Inc. (AMEX AMEX See: American Stock Exchange :COB) announced today that it will release its 2001 third quarter financial results on Monday, November 12, 2001 after the market closes. The Company will provide an update and discuss 2001 operating results via telephone conference on Wednesday, November 13, 2001 at 9:00 A.M. (ET). Individuals wishing to participate in the teleconference should call 800-296-6521 after 8:50 A.M. (ET) on November 13th. From outside the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , call 212-676-5019. Replay of the teleconference will be available from November 13th at 11:00 A.M. (ET) until November 23rd at 11:00 A.M. (ET) by dialing 800-633-8284 from in the United States or 858-812-6440 from outside the United States and entering 19980214. Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to research and development of women's health Women's Health Definition Women's health is the effect of gender on disease and health that encompasses a broad range of biological and psychosocial issues. care and endocrinology products, including those intended to treat infertility, dysmenorrhea dysmenorrhea Pain or cramps before or during menstruation. In primary dysmenorrhea, caused by endocrine imbalances, severity varies widely. Irritability, fatigue, backache, or nausea may also occur. , endometriosis endometriosis (ĕn'dəmē'trē-ō`sĭs), a condition in which small pieces of the endometrium (the lining of the uterus) migrate to other places in the pelvic area. and hormonal deficiencies. Columbia is also developing hormonal products for men and a buccal buc·cal adj. 1. Of, relating to, adjacent to, or in the direction of the cheek. 2. Of or relating to the mouth cavity. buccal delivery system for peptides. Columbia's products primarily utilize the company's patented bioadhesive delivery technology. This press release contains statements that constitute forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Those statements include statements regarding the intent, belief or current expectations of the company and its management team. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements. Such risks and uncertainties include, among other things, timely and successful re-launch of Crinone back into the market place, timely and successful completion of clinical studies, competitive economic and regulatory factors in the pharmaceutical and health care industry, general economic conditions and other risks and uncertainties that may be detailed, from time-to-time, in Columbia's reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion